Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025)

Benitec Biopharma has reported Change in Accured Expenses over the past 7 years, most recently at $19000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $19000.0 for Q4 2025, up 120.43% from a year ago — trailing twelve months through Dec 2025 was $52000.0 (up 161.9% YoY), and the annual figure for FY2025 was -$81000.0, down 307.69%.
  • Change in Accured Expenses reached $19000.0 in Q4 2025 per BNTC's latest filing, down from $37000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $159000.0 in Q1 2025 and bottomed at -$163000.0 in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was $17500.0 (2024), compared with a mean of $13150.0.
  • Peak annual rise in Change in Accured Expenses hit 7850.0% in 2025, while the deepest fall reached 1711.11% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $3000.0 in 2021, then soared by 100.0% to $6000.0 in 2022, then surged by 733.33% to $50000.0 in 2023, then crashed by 286.0% to -$93000.0 in 2024, then skyrocketed by 120.43% to $19000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BNTC at $19000.0 in Q4 2025, $37000.0 in Q3 2025, and -$163000.0 in Q2 2025.